Metcalfe M S, Butterworth P C, White S A, Saunders R N, Murphy G J, Taub N, Veitch P S, Nicholson M L
Department of Surgery, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW UK.
Transplantation. 2001 Jun 15;71(11):1556-9. doi: 10.1097/00007890-200106150-00012.
The decline in heart-beating brainstem dead organ donors has necessitated the search for other organ sources. In the field of renal transplantation one alternative source currently available, but little used, is that of kidneys from non-heart-beating donors (NHBD). Reticence to use NHBD kidneys is in part due to concerns over the effect that warm ischemic may have subsequent graft function. Presented here are the results of the NHBD renal transplants at the Leicester transplant unit, and compared with matched heart-beating donor transplants as a case control analysis.
In order to analyze any differences in graft performance between the two organ sources, the confounding effect of other variables known to influence the outcome of renal transplantation was minimized by matching NHBD and HBD transplants for the following criteria: donor age and sex, first or re-transplant, anastomosis and cold times, tissue match and PRA sensitisation. Transplant performance was assessed primarily by graft survival, the statistical evaluation of which was by log rank analysis of Kaplan-Meier curves.
72 NHBD and 192 HBD transplants were performed over an eight year period. Of the 192 HBD transplants, 105 matched one or more of the NHBD by the criteria outlined above, and thus constituted the control group for comparison. There was no significant difference in overall graft survival between the two groups. The 5 year survival for the NHBD was 73% compared with 65% for HBD kidneys. When death with a functioning graft is treated as censored data, then these figures become 75% and 81% respectively, again without statistical significance.
NHBD kidneys are a valuable additional source of organs for transplantation, with long-term survival, comparable to transplants from HBD.
心跳脑干死亡器官捐献者数量的减少使得人们不得不寻找其他器官来源。在肾移植领域,目前有一种可用但很少使用的替代来源,即非心跳捐献者(NHBD)的肾脏。不愿使用NHBD肾脏的部分原因是担心热缺血对后续移植肾功能可能产生的影响。本文介绍了莱斯特移植中心NHBD肾移植的结果,并与匹配的心跳捐献者移植进行比较,作为病例对照分析。
为了分析两种器官来源之间移植效果的任何差异,通过按照以下标准匹配NHBD和HBD移植,将已知影响肾移植结果的其他变量的混杂效应降至最低:供体年龄和性别、首次移植或再次移植、吻合时间和冷缺血时间、组织配型和PRA致敏情况。移植效果主要通过移植肾存活情况进行评估,其统计评估采用Kaplan-Meier曲线的对数秩分析。
在八年期间共进行了72例NHBD移植和192例HBD移植。在192例HBD移植中,105例根据上述标准与一个或多个NHBD移植匹配,因此构成了用于比较的对照组。两组之间的总体移植肾存活率没有显著差异。NHBD移植肾的5年存活率为73%,而HBD移植肾为65%。当将移植肾仍有功能时的死亡视为截尾数据时,那么这些数字分别变为75%和81%,同样没有统计学意义。
NHBD肾脏是一种有价值的额外移植器官来源,其长期存活率与HBD移植相当。